Usefulness of the 2-year iodine-123 metaiodobenzylguanidine-based risk model for post-discharge risk stratification of patients with acute decompensated heart failure-Reference-Cited by-同舟云学术

Usefulness of the 2-year iodine-123 metaiodobenzylguanidine-based risk model for post-discharge risk stratification of patients with acute decompensated heart failure

Published:2022-01-08 Issue:6 Volume:49 Page:1906-1917
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Tamaki Shunsuke^ORCID,Yamada Takahisa,Watanabe Tetsuya,Morita Takashi,Kawasaki Masato,Kikuchi Atsushi,Kawai Tsutomu,Seo Masahiro,Nakamura Jun,Kayama Kiyomi,Sakamoto Daisuke,Ueda Kumpei,Kogame Takehiro,Tamura Yuto,Fujita Takeshi,Nishigaki Keisuke,Fukuda Yuto,Kokubu Yuki,Fukunami Masatake

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00259-021-05663-y.pdf

Reference37 articles.

1. Chang PP, Wruck LM, Shahar E, Rossi JS, Loehr LR, Russell SD, et al. Trends in hospitalizations and survival of acute decompensated heart failure in four us communities (2005–2014): ARIC Study Community Surveillance. Circulation. 2018;138:12–24. https://doi.org/10.1161/CIRCULATIONAHA.117.027551.

2. Rocha BML, Menezes FL. Acute decompensated heart failure (ADHF): a comprehensive contemporary review on preventing early readmissions and postdischarge death. Int J Cardiol. 2016;223:1035–44. https://doi.org/10.1016/j.ijcard.2016.07.259.

3. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200. https://doi.org/10.1093/eurheartj/ehw128.

4. Ouwerkerk W, Voors AA, Zwinderman AH. Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure. JACC Heart Fail. 2014;2:429–36. https://doi.org/10.1016/j.jchf.2014.04.006.

5. Rahimi K, Bennett D, Conrad N, Williams TM, Basu J, Dwight J, et al. Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Fail. 2014;2:440–6. https://doi.org/10.1016/j.jchf.2014.04.008.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac sympathetic activity and lethal arrhythmic events: insight into bell-shaped relationship between 123I-meta-iodobenzylguanidine activity and event rates;EJNMMI Research;2024-07-21

2. Validation of a Five-Year Prognostic Model Using <sup>123</sup>I-metaiodobenzylguanidine Scintigraphy in Patients with Heart Failure;Annals of Nuclear Cardiology;2023

3. 123I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation;European Journal of Nuclear Medicine and Molecular Imaging;2022-09-08

4. Nuclear Cardiology Data Analyzed Using Machine Learning;Annals of Nuclear Cardiology;2022